Oppn leaders stalling consensus on Land Acquisition Act , says Gadkari

September 15, 2014

New Delhi, Sep 15: Government today sought "consensus" to bring changes in the Land Acquisition Act to make it more investor-friendly but said it was not happening due to the "contradictory views" within political parties which are wanting changes in the legislation.Nitin Gadkari

Rural Development Minister Nitin Gadkari also hit out at the "microscopic minority" of Opposition leaders for stalling the government's efforts to build consensus on bringing changes in the key farmer-friendly Act passed during the UPA's period.

The minister said he was "confused".

"The issue is the microscopic minority leaders sitting in Delhi. Their practical chief ministers are saying something. They are giving in writing (the need for bringing changes in the Act). These people (microscopic minority leaders) are saying something else. I am confused," Gadkari said reacting to questions on the status of the government's efforts to bring changes in the Land Acquisition Act.

Replying to the Opposition's allegations that the government was bringing changes in the Act to please the industry, he also made it clear that the priority of the NDA was welfare of poor and there was "no question of reducing compensation package for farmers whose land is acquired for projects".

"Leaders from every political party were telling me in writing to bring changes in the Act... I wish to make it clear that whenever there will be a consensus on the matter, then the government will take a decision. There is no general consensus on the issue right now," the minister said at a press conference convened to highlight the achievements of his ministries during the first 100 days of the new government.

"Leaders of the parties which have presence in Parliament are saying that you do something to bring changes in Land Acquisition Act. These are people from the CPI (M), Congress, NCP and BJP...," Gadkari said

Gadkari rejected allegations that the government was trying to make the farmer-friendly Act more industry-friendly.

"This is not an issue that favours industry or contractor," he said, adding that the development initiative of the NDA government was to address unemployment and poverty in the backward areas of the country.

"There is no question of doing any injustice to poor. Our government is committed to work for poor people," he said.

He said there is also no question of reducing the compensation package for farmers whose land is acquired for projects.

"We are trying to increase it. There is no compromise on the issue of rehabilitation of poor affected by the projects. We will try to strengthen it," Gadkari said.

He, however, did not specify about the provisions the government intends to change.

In a note sent to the PMO recently, the Rural Development Ministry, which held a meeting of the state Revenue Ministers, has suggested a number of amendments to the Act that seeks to dilute pro-farmer provisions like mandatory consent of at least 70 per cent locals for acquiring land for PPP projects and 80 per cent for acquiring land for private projects.

The ministry's proposals also include dilution of a key clause of Social Impact Assessment study criticised by states as time consuming for industrialisation process.

"The Consent Clause (Section 2(2)) should be re-examined as ownership of land vests with the government in PPP projects. The consent clause should be removed from PPP projects. Alternatively, consent requirement may be brought down to 50 per cent," the ministry has said in its note.

It has said that "mandatory Social Impact Assessment study should be done away with".

SIA should be confined to large projects/PPP projects as it may delay acquisition process.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 7,2020

New Delhi, Mar 7: Prime Minister Narendra Modi turned emotional on Saturday when a woman beneficiary of his government's generic medicine programme told him that she had seen God in him.

Dehradun-resident Deepa Shah, who suffered paralysis in 2011, was interacting with the prime minister through video-conference on the occasion of Jan Aushadhi Diwas.

"I have not seen god, but I have seen God in you," she said, tears rolling down her eyes.

Modi was visibly emotional as the woman repeated her remark.

She also thanked the Uttarakhand chief minister and others who had helped her all along and said doctors had once told her that she cannot be cured.

"But on hearing your voice I have become better," she told Modi while profusely thanking the prime minister for his efforts to reduce the cost of medicines.

An emotional prime minister paused for a moment before telling her that it was her courage that had won over her disease and that she must carry on with the spirit.

Shah was expressing her plight and how she had suffered due to high cost of medicines after she suffered from paralysis in 2011 and has now started saving Rs 3,500 every month after benefitting from the government's low-cost generic medicines programme.

Soon after Shah rose to express her views, Modi asked her to sit and speak as he said she was uncomfortable while standing.

"You have defeated disease with your own will power. Your courage is your god and that same courage has given you the strength to emerge from such a big crisis. You should carry on this confidence in you," Modi told her.

He said some people still keep spreading rumours about generic medicines, going by their past experience, wondering how can medicines be available so cheap and that there must be something wrong with the medicine.

"But, by seeing you countrymen would gain confidence that there is nothing wrong in generic medicines. These medicines are not at all of inferior quality than any other medicine. These medicines have been certified by the best laboratories. These medicines are made in India and is 'Make in India' and are cheap," the prime minister said.

He said there is demand for generic medicines from India across the world and the government has made it mandatory for doctors to prescribe generic medicines to patients, unless necessary.

Comments

Sameeksha
 - 
Monday, 9 Mar 2020

Wowww so emotional... Lol .really god in you??? Drama king and queen

angry indian
 - 
Sunday, 8 Mar 2020

in 2002 riot we have seen shaitan in you..how come shaitan become GOD...

 

did he put atleat one tear for his mother, did he feel sad when pregnant muslim woman brutally murdered..

this guy is 21st century dajjal..

Suresh SS
 - 
Sunday, 8 Mar 2020

Big Nautanki, Dramebaz

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 2,2020

Mar 2: Two more positive cases of the novel coronavirus -- one in Delhi and another in Telangana -were reported, the Union Health Ministry said on Monday.

The person from Delhi had travelled to Italy, it said adding he is being diagnosed at RML hospital.

The other person with the coronavirus infection has a travel history to Dubai, the ministry added.

"Both the patients are stable and being closely monitored," the ministry said.

Sunitha Krishnan is the name of the patient from Telangana and she is a social activist.

Krishnan has tweeted, "So going to enjoy hospitality at Gandhi Hospital for two days as admitted in the isolation ward suspected coronavirus. They have not started the tests yet( 1.30 hrs since I arrived).I believe the results make take 48hrs. At this pace, I have a feeling I am might be here sometime."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.